Objectives: To improve our knowledge and understand how to deal with non-adherence to the support programs and to determine the rate and possible factors related to non-adherence in subjects who attended our smoking cessation clinic.
Materials and methods: This was a case-control study that included 550 subjects who applied to our smoking cessation clinic between June 1, 2011 and December 31, 2011. After a 1-year follow-up period, subjects were divided into two groups: adherent (controls) and non-adherent (cases). Sociodemographic and clinical parameters and smoking habits were evaluated. A p value <0.05 was considered significant.
Results: Of the 550 subjects, the number of cases (non-adherent) was 135 (24.6%), and the number of controls (adherent) was 415 (75.4%). Age to begin smoking was significantly young in subjects with non-adherence to the program (p=0.026). The rate of receiving pharmacotherapy was significantly high in subjects with adherence (p<0.0001). No difference was found between the groups according to varenicline, bupropion, nicotine gum, or combined therapy use, whereas nicotine patch use alone significantly increased the rate of non-adherence (p=0.022). Multivariable logistic regression analysis showed that the age to begin smoking (p=0.045, odds ratio (OR): 1.05, 95% confidence interval (CI): 0.86-0.99) and pharmacotherapy (p<0.0001, OR: 5.00, 95% CI: 2.80-8.94) were independent variables that affected adherence to the program.
Conclusion: Care should be taken in the follow-up period when providing no pharmacotherapy and with subjects who started smoking at a young age.
Conflict of interest statement
Relapse Rate and Factors Related to Relapse in a 1-Year Follow-Up of Subjects Participating in a Smoking Cessation Program.Respir Care. 2015 Dec;60(12):1796-803. doi: 10.4187/respcare.03883. Epub 2015 Aug 18. Respir Care. 2015. PMID: 26286738
A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Clin Ther. 2008. PMID: 18555928 Review.
Pharmacological interventions for promoting smoking cessation during pregnancy.Cochrane Database Syst Rev. 2015 Dec 22;(12):CD010078. doi: 10.1002/14651858.CD010078.pub2. Cochrane Database Syst Rev. 2015. PMID: 26690977 Updated. Review.
Treatment adherence and short-term outcomes of smoking cessation outpatient clinic patients.Tob Induc Dis. 2018 Aug 30;16:38. doi: 10.18332/tid/94212. eCollection 2018. Tob Induc Dis. 2018. PMID: 31516437 Free PMC article.
Varenicline versus nicotine replacement therapy for long-term smoking cessation: an observational study using the Clinical Practice Research Datalink.Health Technol Assess. 2020 Feb;24(9):1-46. doi: 10.3310/hta24090. Health Technol Assess. 2020. PMID: 32079557 Free PMC article. Clinical Trial.